Research Article
Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
Table 1
Accuracy, precision, matrix effect, and recovery of gypenoside A and gypenoside XLIX in rat plasma.
| Compound | Concentration (ng/mL) | Accuracy (%) | Precision (RSD%) | Matrix effect (%) | Recovery (%) | Intraday | Interday | Intraday | Interday |
| Gypenoside A | 2 | 90.1 | 107.5 | 13.8 | 14.9 | 89.9 | 92.7 | 5 | 103.2 | 90.5 | 7.0 | 6.4 | 93.5 | 88.3 | 250 | 100.0 | 102.9 | 8.5 | 7.9 | 93.9 | 95.0 | 2500 | 101.8 | 103.3 | 6.1 | 9.9 | 87.1 | 89.4 | 2 | 91.8 | 113.9 | 10.4 | 12.9 | 90.4 | 97.1 |
| Gypenoside XLIX | 5 | 108.9 | 94.2 | 8.1 | 10.4 | 92.9 | 94.4 | 250 | 106.2 | 106.1 | 8.1 | 11.3 | 94.1 | 93.2 | 2500 | 99.3 | 94.2 | 6.1 | 4.4 | 89.3 | 98.2 |
|
|